SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.

Abstract:

:Multiple myeloma is characterized by increased osteoclast activity that results in bone destruction and lytic lesions. With the prolonged overall patient survival achieved by new treatment modalities, additional drugs are required to inhibit bone destruction. We focused on a novel and more potent structural analog of the nonsteroidal anti-inflammatory drug etodolac, known as SDX-308, and its effects on osteoclastogenesis and multiple myeloma cells. SDX-101 is another structural analog of etodolac that is already used in clinical trials for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). Compared with SDX-101, a 10-fold lower concentration of SDX-308 induced potent (60%-80%) inhibition of osteoclast formation, and a 10- to 100-fold lower concentration inhibited multiple myeloma cell proliferation. Bone resorption was completely inhibited by SDX-308, as determined in dentin-based bone resorption assays. SDX-308 decreased constitutive and RANKL-stimulated NF-kappaB activation and osteoclast formation in an osteoclast cellular model, RAW 264.7. SDX-308 effectively suppressed TNF-alpha-induced IKK-gamma and IkappaB-alpha phosphorylation and degradation and subsequent NF-kappaB activation in human multiple myeloma cells. These results indicate that SDX-308 effectively inhibits multiple myeloma cell proliferation and osteoclast activity, potentially by controlling NF-kappaB activation signaling. We propose that SDX-308 is a promising therapeutic candidate to inhibit multiple myeloma growth and osteoclast activity and that it should receive attention for further study.

journal_name

Blood

journal_title

Blood

authors

Feng R,Anderson G,Xiao G,Elliott G,Leoni L,Mapara MY,Roodman GD,Lentzsch S

doi

10.1182/blood-2006-07-027458

subject

Has Abstract

pub_date

2007-03-01 00:00:00

pages

2130-8

issue

5

eissn

0006-4971

issn

1528-0020

pii

blood-2006-07-027458

journal_volume

109

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.

    abstract::Prophylactic fluconazole prevents candidiasis; however, this drug has no activity against molds. We performed a randomized trial to determine whether prophylactic itraconazole prevents invasive mold infections (IMIs). A total of 304 patients receiving allogeneic stem cell transplants (SCT) were randomized to receive f...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2003-08-2644

    authors: Marr KA,Crippa F,Leisenring W,Hoyle M,Boeckh M,Balajee SA,Nichols WG,Musher B,Corey L

    更新日期:2004-02-15 00:00:00

  • Fcγ receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells.

    abstract::The reactivation of human cytomegalovirus (HCMV) poses a serious health threat to immune compromised individuals. As a treatment strategy, dendritic cell (DC) vaccination trials are ongoing. Recent work suggests that BDCA-3(+) (CD141(+)) subset DCs may be particularly effective in DC vaccination trials. BDCA-3(+) DCs ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-434498

    authors: Flinsenberg TW,Compeer EB,Koning D,Klein M,Amelung FJ,van Baarle D,Boelens JJ,Boes M

    更新日期:2012-12-20 00:00:00

  • Translation of the Philadelphia chromosome into therapy for CML.

    abstract::Throughout its history, chronic myeloid leukemia (CML) has set precedents for cancer research and therapy. These range from the identification of the first specific chromosomal abnormality associated with cancer to the development of imatinib as a specific, targeted therapy for the disease. The successful development ...

    journal_title:Blood

    pub_type: 历史文章,杂志文章,评审

    doi:10.1182/blood-2008-07-077958

    authors: Druker BJ

    更新日期:2008-12-15 00:00:00

  • Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF.

    abstract::We report long-term results of treatment of myelodysplastic syndrome (MDS) with erythropoietin and granulocyte colony-stimulating factor (G-CSF). A total of 129 patients were followed up 45 months after last inclusion in the Nordic MDS Group studies. Erythroid response rate was 39% and median response duration 23 mont...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-10-3872

    authors: Jädersten M,Montgomery SM,Dybedal I,Porwit-MacDonald A,Hellström-Lindberg E

    更新日期:2005-08-01 00:00:00

  • Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis.

    abstract::Delivery of biologically active peptides into human polymorphonuclear neutrophils (PMNs) has implications for studying cellular functions and may be therapeutically relevant. The transcription factor nuclear factor-kappaB (NF-kappaB) regulates the expression of multiple genes controlling inflammation, proliferation, a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2960

    authors: Choi M,Rolle S,Wellner M,Cardoso MC,Scheidereit C,Luft FC,Kettritz R

    更新日期:2003-09-15 00:00:00

  • The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells.

    abstract::Gene transfer in human hematopoietic stem cells (HSCs) has great potential for both gene therapy and the understanding of hematopoiesis. As HSCs have extensive proliferative capacities, stable gene transfer should include genomic integration of the transgene. Lentiviral vectors are now preferred to oncoretroviral vect...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sirven A,Pflumio F,Zennou V,Titeux M,Vainchenker W,Coulombel L,Dubart-Kupperschmitt A,Charneau P

    更新日期:2000-12-15 00:00:00

  • Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers.

    abstract::Patients referred to tertiary care centers occasionally may have their diagnostic procedures repeated and have a final diagnosis that differs from that of the referring center. The aim of this study was to evaluate discordance rates and their clinical implications in the diagnosis of patients with myelodysplastic synd...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-342642

    authors: Naqvi K,Jabbour E,Bueso-Ramos C,Pierce S,Borthakur G,Estrov Z,Ravandi F,Faderl S,Kantarjian H,Garcia-Manero G

    更新日期:2011-10-27 00:00:00

  • Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children.

    abstract::In a double-blind study, we compared the postoperative (post-op) blood loss in 161 children undergoing open heart surgery with cardiopulmonary bypass whose immediate post-op transfusion requirements were met with either very fresh whole blood (VFWB), 24- to 48-hour-old whole blood or reconstituted whole blood (packed ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Manno CS,Hedberg KW,Kim HC,Bunin GR,Nicolson S,Jobes D,Schwartz E,Norwood WI

    更新日期:1991-03-01 00:00:00

  • Hematopoietic stem-cell behavior in nonhuman primates.

    abstract::Little is known about the behavior of hematopoietic stem cells (HSCs) in primates because direct observations and competitive-repopulation assays are not feasible. Therefore, we used 2 different and independent experimental strategies, the tracking of transgene expression after retroviral-mediated gene transfer (N = 1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-075382

    authors: Shepherd BE,Kiem HP,Lansdorp PM,Dunbar CE,Aubert G,LaRochelle A,Seggewiss R,Guttorp P,Abkowitz JL

    更新日期:2007-09-15 00:00:00

  • Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets.

    abstract::Early in life, thymic export establishes the size and the diversity of the human naive T-cell pool. Yet, on puberty thymic activity drastically decreases. Because the overall size of the naive T-cell pool decreases only marginally during ageing, peripheral postthymic expansion of naive T cells has been postulated to a...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2008-02-139154

    authors: Kohler S,Thiel A

    更新日期:2009-01-22 00:00:00

  • Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis.

    abstract::In the absence of conclusive assays capable of determining the functionality of ex vivo expanded human hematopoietic progenitor cells, we combined cell tracking with the membrane dye PKH2, immunostaining for CD34, and limiting dilution analysis to estimate the frequency of long-term hematopoietic culture-initiating ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Traycoff CM,Kosak ST,Grigsby S,Srour EF

    更新日期:1995-04-15 00:00:00

  • Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

    abstract::Circulating endothelial progenitor cells (EPCs) are thought to contribute to angiogenesis following vascular injury, stimulating interest in their ability to mediate therapeutic angiogenesis. However, the number of EPCs in the blood is low, limiting endogenous repair, and a method to rapidly mobilize EPCs has not been...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-06-030577

    authors: Shepherd RM,Capoccia BJ,Devine SM,Dipersio J,Trinkaus KM,Ingram D,Link DC

    更新日期:2006-12-01 00:00:00

  • Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.

    abstract::Hematopoietic growth factors (HGFs) interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) individually have been shown to increase the percentage of acute myeloid leukemia (AML) blasts in S phase and enhance the cytotoxic effects of Ara-C against these blasts in culture. We compared in vit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bhalla K,Holladay C,Arlin Z,Grant S,Ibrado AM,Jasiok M

    更新日期:1991-11-15 00:00:00

  • Detection of factor VIII inhibitors with the partial thromboplastin time.

    abstract::Variations of the partial thromboplastin time (PTT) were tested to determine the best screening method for detection of inhibitors of factor VIII. Variables tested included the duration of preincubation of a mixture of patient plasma and factor VIII source (normal plasma), the ratio of the patient plasma to the normal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lossing TS,Kasper CK,Feinstein DI

    更新日期:1977-05-01 00:00:00

  • Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma.

    abstract::Interferon (IFN) therapy has become widely used for the treatment of chronic myelogenous leukemia. Hematologic remissions can be induced in about 60% of patients. Moreover, in a small number of patients loss of the Philadelphia (Ph) chromosome and of the BCR-ABL rearrangement is observed. We have used genomic Southern...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Opalka B,Wandl UB,Becher R,Kloke O,Nagel-Hiemke M,Moritz T,Beer U,Seeber S,Niederle N

    更新日期:1991-11-01 00:00:00

  • Expression of plasma glutathione peroxidase in human liver in addition to kidney, heart, lung, and breast in humans and rodents.

    abstract::We analyzed the expression of plasma glutathione peroxidase (GSHPx-P) messenger RNA (mRNA) in mouse, rat, and human tissues, using a human GSHPx-P cDNA clone as the probe. Unlike the classical cellular glutathione peroxidase (GSHPx-1), GSHPx-P expression appears to be tissue-specific. In the mouse and rat, kidney expr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chu FF,Esworthy RS,Doroshow JH,Doan K,Liu XF

    更新日期:1992-06-15 00:00:00

  • Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets.

    abstract::Hematopoietic fate maps in the developing mouse embryo remain imprecise. Definitive, adult-type hematopoiesis first appears in the fetal liver, then progresses to the spleen and bone marrow. Clonogenic common lymphoid progenitors and clonogenic common myeloid progenitors (CMPs) in adult mouse bone marrow that give ris...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.627

    authors: Traver D,Miyamoto T,Christensen J,Iwasaki-Arai J,Akashi K,Weissman IL

    更新日期:2001-08-01 00:00:00

  • Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.

    abstract::In human immunodeficiency virus (HIV)-1 infection, decrease of telomere length is mainly found in CD8(+) T cells and not in CD4(+) T cells. Telomerase, a ribonucleoprotein enzyme that can synthesize telomeric sequence onto chromosomal ends, can compensate for telomere loss. Here, we investigated if telomerase activity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wolthers KC,Otto SA,Wisman GB,Fleury S,Reiss P,ten Kate RW,van der Zee AG,Miedema F

    更新日期:1999-02-01 00:00:00

  • Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.

    abstract::CC chemokine receptor (CCR) 9, the receptor for the CC-chemokine CCL25/thymus-expressed chemokine (TECK), is mainly expressed by thymocytes and by intraepithelial (IEL) and lamina propria lymphocytes of the small intestine. To study the biologic role of CCR9, a mouse strain was generated in which the CCR9 gene was del...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.9.2626

    authors: Wurbel MA,Malissen M,Guy-Grand D,Meffre E,Nussenzweig MC,Richelme M,Carrier A,Malissen B

    更新日期:2001-11-01 00:00:00

  • Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.

    abstract::Pacritinib (SB1518) is a Janus kinase 2 (JAK2), JAK2(V617F), and Fms-like tyrosine kinase 3 inhibitor that does not inhibit JAK1. It demonstrated a favorable safety profile with promising efficacy in phase 1 studies in patients with primary and secondary myelofibrosis (MF). This multicenter phase 2 study further chara...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2013-02-484832

    authors: Komrokji RS,Seymour JF,Roberts AW,Wadleigh M,To LB,Scherber R,Turba E,Dorr A,Zhu J,Wang L,Granston T,Campbell MS,Mesa RA

    更新日期:2015-04-23 00:00:00

  • The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.

    abstract::A deficiency of adenosine deaminase, an enzyme important in purine nucleoside catabolism, is associated with a severe combined immunodeficiency disease in children. Inhibition of this enzyme in vitro and in vivo results in an impairment in lymphoblast proliferation. We have investigated the pharmacologic inhibition of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Grever MR,Siaw MF,Jacob WF,Neidhart JA,Miser JS,Coleman MS,Hutton JJ,Balcerzak SP

    更新日期:1981-03-01 00:00:00

  • EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.

    abstract::Autologous T cells targeting Epstein-Barr virus (EBV) latent membrane proteins (LMPs) have shown safety and efficacy in the treatment of patients with type 2 latency EBV-associated lymphomas for whom standard therapies have failed, including high-dose chemotherapy followed by autologous stem-cell rescue. However, the ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2018-07-863654

    authors: McLaughlin LP,Rouce R,Gottschalk S,Torrano V,Carrum G,Wu MF,Hoq F,Grilley B,Marcogliese AM,Hanley PJ,Gee AP,Brenner MK,Rooney CM,Heslop HE,Bollard CM

    更新日期:2018-11-29 00:00:00

  • There's no such fool like an immunosenescent fool.

    abstract::In this issue of Blood, Stepensky et al provide an astute description of immunosenescence arising from deficiency in tripeptidyl peptidase II (TPPII). Senescence of T and B lymphocytes is a striking finding, which has recently come into the limelight because it can be linked to primary immunodeficiency syndromes with ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-12-614149

    authors: Seidel MG

    更新日期:2015-01-29 00:00:00

  • Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.

    abstract::Multiple mechanisms operate to ensure T-cell tolerance toward self-antigens. Three main processes have been described: clonal deletion, anergy, and deviation to CD4(+) regulatory T cells (Tregs) that suppress autoreactive T cells that have escaped the first 2 mechanisms. Although it is accepted that dendritic cells (D...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336115

    authors: Morlacchi S,Soldani C,Viola A,Sarukhan A

    更新日期:2011-07-28 00:00:00

  • Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: potential mechanisms for survival enhancing effects.

    abstract::Thrombopoietin (Tpo) has proliferative and maturational effects on immature and more committed cells, respectively. We previously reported a role for Tpo as a survival factor in the factor-dependent human cell line M07e by demonstrating that Tpo suppresses apoptosis in the absence of induced proliferation. Wild-type p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ritchie A,Gotoh A,Gaddy J,Braun SE,Broxmeyer HE

    更新日期:1997-12-01 00:00:00

  • Specific involvement of caspases in the differentiation of monocytes into macrophages.

    abstract::Caspases are cysteine proteases involved in apoptosis and cytokine maturation. In erythroblasts, keratinocytes, and lens epithelial cells undergoing differentiation, enucleation has been regarded as a caspase-mediated incomplete apoptotic process. Here, we show that several caspases are activated in human peripheral b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1778

    authors: Sordet O,Rébé C,Plenchette S,Zermati Y,Hermine O,Vainchenker W,Garrido C,Solary E,Dubrez-Daloz L

    更新日期:2002-12-15 00:00:00

  • Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.

    abstract::Leukemia relapse is a major cause of treatment failure for patients with acute leukemia given allogeneic bone marrow transplantation (BMT). This study evaluated whether a reduction of the dosage of cyclosporine-A (Cs-A) used for graft versus host disease (GVHD) prophylaxis could reduce relapse rate (RR) in children wi...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Locatelli F,Zecca M,Rondelli R,Bonetti F,Dini G,Prete A,Messina C,Uderzo C,Ripaldi M,Porta F,Giorgiani G,Giraldi E,Pession A

    更新日期:2000-03-01 00:00:00

  • Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.

    abstract::Chimeric antigen receptor (CAR) T cells targeting CD19 have emerged as a leading engineered T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. The phase 1/2 clinical trials that led to US Food and Drug Administration approval excluded patients with central nervous system (CNS) involvement, due to stri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001694

    authors: Frigault MJ,Dietrich J,Martinez-Lage M,Leick M,Choi BD,DeFilipp Z,Chen YB,Abramson J,Crombie J,Armand P,Nayak L,Panzini C,Riley LS,Gallagher K,Maus MV

    更新日期:2019-09-12 00:00:00

  • Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells.

    abstract::Because of their potent immunoregulatory capacity, dendritic cells (DCs) have been exploited as therapeutic tools to boost immune responses against tumors or pathogens, or dampen autoimmune or allergic responses. Murine bone marrow-derived DCs (BM-DCs) are the closest known equivalent of the blood monocyte-derived DCs...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-204321

    authors: Creusot RJ,Yaghoubi SS,Chang P,Chia J,Contag CH,Gambhir SS,Fathman CG

    更新日期:2009-06-25 00:00:00

  • Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.

    abstract::Bcl-2 protein expression has been associated with poor prognosis in patients with noncutaneous diffuse large B-cell lymphomas. In primary cutaneous large B-cell lymphomas, the location on the leg, the round-cell morphology defined as the predominance of centroblasts and immunoblasts over large centrocytes, and multipl...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2003-08-2726

    authors: Grange F,Petrella T,Beylot-Barry M,Joly P,D'Incan M,Delaunay M,Machet L,Avril MF,Dalac S,Bernard P,Carlotti A,Esteve E,Vergier B,Dechelotte P,Cassagnau E,Courville P,Saiag P,Laroche L,Bagot M,Wechsler J

    更新日期:2004-05-15 00:00:00